SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-239 Cr | ₹-360 Cr | ₹-429 Cr | ₹-69 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹-239 Cr |
| Mar2025 | ₹-360 Cr |
| Mar2024 | ₹-429 Cr |
| Mar2023 | ₹-69 Cr |
How is Cash Flow from Operating Activities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-239 Cr | Negative | |
| Mar2025 | ₹-360 Cr | Negative | |
| Mar2024 | ₹-429 Cr | Negative | |
| Mar2023 | ₹-69 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,678.2 Cr | 6.5% | 5.5% | 37% | Stock Analytics | |
| PRIME FOCUS | ₹26,186.3 Cr | 0.5% | 9.3% | 90.6% | Stock Analytics | |
| SAGILITY | ₹21,520.1 Cr | 2.6% | 6.4% | 0.3% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,404.0 Cr | 0.4% | -4.2% | -42% | Stock Analytics | |
| INDEGENE | ₹14,413.4 Cr | 1.2% | 5.6% | 1.2% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,356.3 Cr | 5.3% | -2.4% | -15.3% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 6.5% |
5.5% |
37% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses